Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
By Ashley Capoot & Annika Kim Constantino
All coverage
Wegovy to be sold on Hims, Ro and LifeMD for reduced price
By Katie Kindelan
Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy
By Andrea Park
Hims & Hers Stock Soars on Pact With Novo Nordisk for Weight-Loss Drug Wegovy
By Josh Nathan-kazis & Elsa Ohlen
Hims and Novo Nordisk partner to offer discounted Wegovy
By Shelby Livingston
Hims Catapults After Inking A Massive Deal With Novo Nordisk
By Allison Gatlin
Hims & Hers, Novo Nordisk partner on GLP-1s
By Brock Ew Turner
Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
By Sriparna Roy & Patrick Wingrove
Hims & Hers partners with Novo Nordisk to sell Wegovy
By Aislinn Murphy
You might soon be able to get Wegovy from an online shop — here is where you need to visit
By Julia Musto
America set for Ozempic EXPLOSION as drug is made available on telehealth giant for first time
By Sadie Whitelocks
Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk
By Aaron McDade
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
By Michael Grothaus
RO INTEGRATES WITH NOVOCARE® PHARMACY TO PROVIDE SEAMLESS ACCESS TO WEGOVY® AT THE LOWEST CASH PRICE
Hims & Hers surges after announcing partnership with Ozempic maker Novo Nordisk
By J. Edward Moreno Del Angel
Hims & Hers stock rises on Novo Nordisk pact (update) (NVO)
By Dulan Lokuwithana
Hims & Hers partners with Novo Nordisk to sell Wegovy on its platform
By Sriparna Roy & Anil D'silva
Wegovy to be sold on Hims, Ro and LifeMD for reduced price
By Katie Kindelan